-
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Mar 18, 2026, 21:38 PM -
THE VALUE VOCABULARY: AN ANALYSIS OF SOCIETAL TERMS IN CDA-AMC AND INESSS HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
EXPLORING PHYSICIANS’ PERSPECTIVES ON BARRIERS TO ENGAGING PATIENTS WITH RARE DISEASES AND/OR THEIR CAREGIVERS IN SHARED DECISION-MAKING IN THE UNITED STATES (US): FINDINGS FROM A CROSS-SECTIONAL SURVEY
Mar 18, 2026, 21:38 PM -
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF RSV MATERNAL IMMUNIZATION [RSVPREF] IN THE DOMINICAN REPUBLIC: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
IMPACT OF PD-1 AND PD-L1 INHIBITORS ON PATIENT-REPORTED OUTCOMES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
BARRIERS TO HEALTHCARE USE AMONG ADOLESCENTS IN CONFLICT-AFFECTED IDP CAMPS IN NORTHEASTERN NIGERIA: REAL-WORLD EVIDENCE ON ACCESS, EQUITY, AND SERVICE DELIVERY COSTS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND EFFICACY OF FIRST-LINE THERAPIES IN PATIENTS WITH MET EXON 14 SKIPPING-MUTATED NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
WHEN HYPERTENSION REACHES THE HOSPITAL: PROFILING PATIENTS ADMITTED WITH HYPERTENSION AS A PRIMARY DIAGNOSIS IN CHILE’S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
THE ACCESSIBILITY OF ANTI-CANCER DRUGS IN CHINA'S URBAN CUSTOMIZED COMMERCIAL MEDICAL INSURANCE
Mar 18, 2026, 21:38 PM -
MEDICARE COST OF MINIMALLY INVASIVE BIOMARKER TESTS TO DETECT DONOR-DERIVED CELL-FREE DNA (DD-CFDNA)
Mar 18, 2026, 21:38 PM -
EVALUATING PATIENT PREFERENCES FOR COPD MAINTENANCE TREATMENT DELIVERY DEVICES: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON AND COST-UTILITY OF ZORIFERTINIB VERSUS OSIMERTINIB IN TREATING NEWLY DIAGNOSED EGFR-MUTANT NSCLC WITH CNS METASTASES IN CHINA
Mar 18, 2026, 21:38 PM -
REAL-WORLD INSIGHTS INTO OBESITY PATHWAYS, PRESCRIBING, PATIENT COMPLEXITY, AND CARE GAPS THROUGH PRIMARY CARE DATABASES
Mar 18, 2026, 21:38 PM -
POST-PANDEMIC BURDEN OF COVID-19 AMONG HIGH-RISK PATIENTS WITH ACUTE INFECTION: A CROSS-SECTIONAL SURVEY IN GERMANY
Mar 18, 2026, 21:38 PM -
VARIATION IN AVERAGE INCREMENTAL COST-EFFECTIVENESS RATIOS ACROSS DISEASE GROUPS AND THE DISTRIBUTION OF RESEARCH AND DEVELOPMENT FUNDS
Mar 18, 2026, 21:38 PM -
THE ROLE OF SOCIAL SUPPORT AND SOCIOECONOMIC STATUS ON ANNUAL GYNECOLOGIST VISIT AMONG YOUNG FEMALES
Mar 18, 2026, 21:38 PM -
IMPACT OF EXPEDITED REGULATORY PATHWAYS ON REIMBURSED ACCESS IN EU4,UK,US
Mar 18, 2026, 21:38 PM -
TURNING DATA INTO BUSINESS MODEL INNOVATION: A PRAGMATIC CRITICAL REALIST APPROACH TO THE EUROPEAN PARADOX IN A POST-MFN WORLD
Mar 18, 2026, 21:38 PM
